Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action.


Journal

Naunyn-Schmiedeberg's archives of pharmacology
ISSN: 1432-1912
Titre abrégé: Naunyn Schmiedebergs Arch Pharmacol
Pays: Germany
ID NLM: 0326264

Informations de publication

Date de publication:
07 2020
Historique:
received: 29 04 2020
accepted: 10 05 2020
pubmed: 29 5 2020
medline: 7 7 2020
entrez: 29 5 2020
Statut: ppublish

Résumé

Ivermectin is an antiparasitic drug that has shown also an effective pharmacological activity towards various infective agents, including viruses. This paper proposes an alternative mechanism of action for this drug that makes it capable of having an antiviral action, also against the novel coronavirus, in addition to the processes already reported in literature.

Identifiants

pubmed: 32462282
doi: 10.1007/s00210-020-01902-5
pii: 10.1007/s00210-020-01902-5
pmc: PMC7251046
doi:

Substances chimiques

Antiviral Agents 0
Ivermectin 70288-86-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1153-1156

Références

J Membr Biol. 1986;90(3):231-40
pubmed: 3735403
Antimicrob Agents Chemother. 2013 Feb;57(2):1040-6
pubmed: 23165468
Eur J Clin Pharmacol. 1990;39(6):607-8
pubmed: 2095348
AAPS J. 2008;10(1):42-6
pubmed: 18446504
Antimicrob Resist Infect Control. 2018 Feb 20;7:27
pubmed: 29468054
Int J Syst Evol Microbiol. 2002 Nov;52(Pt 6):2163-2168
pubmed: 12508884
Biophys J. 2003 Jul;85(1):70-4
pubmed: 12829465
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32284379
J Virol. 2009 Jan;83(1):58-64
pubmed: 18922875
Anticancer Res. 2019 Sep;39(9):4837-4843
pubmed: 31519586
Sci Rep. 2016 Mar 18;6:23138
pubmed: 26988202
Antiviral Res. 2020 May;177:104760
pubmed: 32135219
Allergy. 2017 Aug;72(8):1212-1221
pubmed: 28052336
Vet Parasitol. 2016 Aug 15;226:1-4
pubmed: 27514873
J Parasitol. 2011 Dec;97(6):1190-2
pubmed: 21756054
Biochim Biophys Acta. 1989 Jul 10;982(2):303-6
pubmed: 2752030
Curr Opin Cell Biol. 2019 Jun;58:50-60
pubmed: 30826604
Antiviral Res. 2013 Sep;99(3):301-6
pubmed: 23769930
PLoS Pathog. 2010 Nov 04;6(11):e1001176
pubmed: 21079686
Biochem J. 2012 May 1;443(3):851-6
pubmed: 22417684
Cancers (Basel). 2018 Sep 27;10(10):
pubmed: 30262730
Am J Cancer Res. 2018 Feb 01;8(2):317-331
pubmed: 29511601
Antiviral Res. 2013 Dec;100(3):662-72
pubmed: 24161512
Antimicrob Agents Chemother. 1979 Dec;16(6):808-12
pubmed: 119484
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
J Biomol Screen. 2011 Feb;16(2):192-200
pubmed: 21297106
Antiviral Res. 2020 May;177:104759
pubmed: 32130973
Antiviral Res. 2018 Nov;159:55-62
pubmed: 30266338
Antiviral Res. 2012 Sep;95(3):202-6
pubmed: 22750233
Trends Parasitol. 2005 Nov;21(11):530-2
pubmed: 16126457
J Antibiot (Tokyo). 2017 May;70(5):495-505
pubmed: 28196978

Auteurs

Emanuele Rizzo (E)

Department of Prevention, Local Health Authority of Lecce (ASL Lecce), Lecce, Italy. emanuele.rizzo@email.com.
Italian Society of Environmental Medicine (SIMA), Milan, Italy. emanuele.rizzo@email.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH